KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Non-cash Items (2019 - 2025)

Globus Medical's Non-cash Items history spans 7 years, with the latest figure at $53.6 million for Q3 2025.

  • For Q3 2025, Non-cash Items rose 627.04% year-over-year to $53.6 million; the TTM value through Sep 2025 reached $53.6 million, up 627.04%, while the annual FY2024 figure was $6.5 million, 89.46% down from the prior year.
  • Non-cash Items reached $53.6 million in Q3 2025 per GMED's latest filing, down from $66.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $320.0 million in Q2 2021 to a low of $5.1 million in Q1 2021.
  • Average Non-cash Items over 5 years is $80.5 million, with a median of $45.0 million recorded in 2023.
  • Peak YoY movement for Non-cash Items: soared 5598.02% in 2021, then plummeted 98.02% in 2022.
  • A 5-year view of Non-cash Items shows it stood at $231.9 million in 2021, then grew by 1.01% to $234.2 million in 2022, then plummeted by 73.75% to $61.5 million in 2023, then plummeted by 89.46% to $6.5 million in 2024, then soared by 726.2% to $53.6 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Non-cash Items are $53.6 million (Q3 2025), $66.3 million (Q2 2025), and $7.0 million (Q1 2025).